(Received for publication March 1 1, 1996) In the course of a screening program, a novel quinolone antibiotic, YM-30059 ( Fig. 1 ) was isolated from the culture broth of Arthrobacter sp. YL-02729S. YM-30059 exhibited relatively high antibacterial activities against
Gram-positive bacteria including multiple-drug resistant Staphylococcus aureus and S. epidermidis. The present paper deals with the taxonomy of the producing organism, fermentation, isolation, structure elucidation and biological activity of the new antibiotic.
Microorganism
Strain YL-02729S was freshly isolated from a soil collected from West Kalimantan, Indonesia. Colonies of strain YL-02729Swere semi-transparent, white cream, circular and convex on various complex media. By light and electron microscopic observations, strain YL-02729S was Gram-variable rods. A rod-coccus growth change occurred during cultivation in the various complex media. Primary branching occurred after cultivation for 24 to 48 hours, but no true mycelia were produced in any stage of the cell cycle. The temperature range for growth was 15 to 37°C. The cell wall peptide glycan contains lysine as a diamino acid. It was obligately aerobic. Catalase, gelatinase and DNase reactions were positive. The major menaquinones were MK-9 (H2). The mol% of G+C of the DNA was 67.4 (HPLC method 1>2)). Based on the characteristics described above, the strain was identified as a memberof the genus Arthrobacter, and named Arthrobacter sp. YL-02729S.
The type strain has been deposited at National In- 
Fermentation
A thawed suspension of the producing organism was used to inoculate a 500-ml Erlenmeyer flask containing 100ml of the seed medium which consisted of glucose 1%, potato starch 2%, yeast extract 0.5%, polypepton (Nihon Pharmaceutical Co., Ltd.) 0.5% and CaCO3 0.4%, pH 7.3. The flask was incubated at 28°C for 2days on a rotary shaker at 220rpm. The seed culture (2ml) was transferred to 500-ml Erlenmeyer flasks containing 100ml of the same medium. The fermentation was carried out at 28°C for 3days on a rotary shaker at 220 rpm.
Isolation and Purification
The purification procedure for YM-30059is outlined in Fig. 2 . The fermentation broth of Arthrobacter sp.
YL-02729S (2.5liters)
was adjusted to pH 7.0 and extracted with ethyl acetate. The organic layer was evaporated in vacuo to remove ethyl acetate. The crude extract (2.52g) was subjected to silica gel column chromatography (24 x 500mm) eluting with benzeneacetone (7:3) as solvent. The fractions exhibiting antibacterial activity against S. aureus FAD209P were collected and evaporated in vacuo. The extract (98.1 mg) was dissolved in methanol and applied to preparative HPLC (column; Shimadzu STR-ODS, 20 x 250mm, flow rate; 5ml/minute).
The column was developed with methanol-50niM phosphate buffer (pH 4.35)-tetrahydrofuran (70 : 20 : 10), and the main peak was collected (Fig. 3) . The peak fraction was evaporated in vacuo to obtain YM-30059 (14.0mg). The area of diagonals is the peak of YM-30059. The clinically isolated strain which shows resistance to /?-lactams, macrolides and quinolones.
because the chemical shift of C-4' (3 34.0) was over 3 30.03). A daughter ion at m/z 283 (M-OH+H)+ in the mass spectrum and the absorption band at 3418 cm" * in the IR spectrum indicated the presence of hydroxyl.
From these results, the hydroxyl was attached to N-l. The structure ofYM-30059 was determined to be (E)Ahydroxy-3-methyl-2-(2-nonenyl)-4~quinolone.
Biological Activities
The antibacterial activity of YM-30059is shown in Table 3 . MICs were determined by the serial agar dilution method using Mueller-Hinton medium. YM-30059 showed moderate antibacterial activities against Grampositive bacteria including multiple-drug resistant S. aureus and S. epidermidis. The cytotoxic activity of YM-30059 was examined against HeLa S3 cells in vitro. HeLa S3 cells were cultured in Ham's F12 supplemented with 10% fetal bovine serum and 20mMHEPES buffer. When the cells were exposed to the antibiotic for 72hours in a humidified atmosphere containing 5% CO2, the value of IC50 was 0.59 /ig/ml. Further examinations were conducted to evaluate the biological properties of YM-30059 and revealed that YM-30059was a potent inhibitor of Iipoxygenase4'5). KF8940, whose chemical structure is similar to YM-30059, has also been reported as a inhibitor of lipoxygenase6).
